Cardiovascular Risk in Toledo Population

Cardiovascular Diseases Clinical Trial

— RICARTO  

Official title:

RIesgo CARdiovascular y Eventos Cardiovasculares en la población General Del área Sanitaria de TOledo

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03294369
• Other study ID #: RICARTO
• Status: Recruiting
• Start date: April 1, 2011
• Est. completion date: December 31, 2020

Study information

• Verified date: January 2020
• Source: Castilla-La Mancha Health Service
• Contact: Gustavo C Rodriguez-Roca, MD, PhD
• Phone: 608293478
• Email: gcrodriguezroca[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and cardiovascular disease (CVD) in general population of the sanitary area of Toledo.

Description:

Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.

Clinical history, physical examination and complementary tests are being performed.

Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the "Virgen de la Salud" hospital of Toledo.

CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.

Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 3125
• Est. completion date: December 31, 2020
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subjects aged 18 years or older, randomly selected from a database of health cards stratified by age and gender

Exclusion Criteria:

• Individulas aged under 18 years.

• Subjects who do not sign the informed consent.

• Subjects that due to different conditions (physical, mental or social) is expected that do not complete the expected follow-up.

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Cardiovascular Risk Factor

Intervention

Other:
• Observational
This is an observational study. No specific diagnostic or therapeutic procedure will be performed due to the study.

Locations

Country	Name	City	State
Spain	Avenida de Irlanda, 12, 2º A	Toledo

Sponsors (3)

Lead Sponsor	Collaborator
Castilla-La Mancha Health Service	Castile-La Mancha Government (Socio-Sanitary Foundation of Castile-La Mancha), SEMERGEN (Spanish Society of Primary Care Physicians)

Country where clinical trial is conducted

Spain, 

References & Publications (5)

Rodríguez Padial L, Segura Fragoso A, Alonso Moreno FJ, Arias MA, Villarín Castro A, Rodríguez Roca GC. Blood pressure differences between one automatic measurement and the mean value of 3 automatic measurements. SPRINT trial. Med Clin (Barc). 2017 Jul 21 — View Citation

Rodríguez-Roca GC, Rodríguez-Padial L, Alonso-Moreno FJ, Romero-Gutiérrez A, Akerström F, Segura-Fragoso A, Villarín-Castro A, Hernández-Moreno J, Menchén-Herreros A, Gómez-Serranillos M, Artigao-Rodenas LM; grupo de trabajo del estudio RICARTO. [Lipid pr — View Citation

Rodríguez-Roca GC, Rodríguez-Padial L, Alonso-Moreno FJ, Segura-Fragoso A, Villarín-Castro A, Rodríguez-García ML, Menchén-Herreros A, Rojas-Martelo GA, Fernández-Conde JA, Artigao-Rodenas LM, Carbayo-Herencia JA, Escobar-Cervantes C, Hernández-Moreno J, — View Citation

Rodríguez-Roca GC, Segura-Fragoso A, Villarín-Castro A, Alonso-Moreno FJ, Rodríguez-Padial L, Rodríguez-García ML, Fernández-Conde JA, Rojas-Martelo GA, Menchén-Herreros A, Escobar-Cervantes C, Fernández-Martín J, Artigao-Rodenas LM, Carbayo-Herencia JA, — View Citation

Rodriguez-Roca GC, Villarín-Castro A, Carrasco-Flores J, Artigao-Rodenas LM, Carbayo-Herencia JA, Escobar-Cervantes C, Alonso-Moreno FJ, Segura-Fragoso A, Gómez-Serranillos M, Hernández-Moreno J; RICARTO (Riesgo Cardiovascular Y Eventos Cardiovasculares E — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assess cardiovascular risk of the study population	Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.	December 2020
Primary	Prevalence of cardiovascular risk factors	To assess the prevalence of cardiovascular risk factors	December 2020
Primary	Prevalence of cardiovascular disease	To assess the prevalence of cardiovascular disease	December 2020